Steven Perrin insider trades

Open-market stock purchases and sales by Steven Perrin, President at Eledon Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 1, 2022.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -11%.

Recent trades

DateStockTradeValue
Jul 31, 2026ELDN Eledon Pharmaceuticals, IncBought (not open market)—
Jul 31, 2026ELDN Eledon Pharmaceuticals, IncSold (not open market)$244K

Companies traded

  • ELDN Eledon Pharmaceuticals, Inc: 1 buy, last Jul 31, 2026

Get free alerts when Steven Perrin files a new trade →